Table of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Treatment
2.3.2 Market Size By Route of Administration
2.3.2 Market Size By Age
2.3.2 Market Size By Availability
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Prescription Volume Trends (2020–2032)
4.1.1 Global and regional trends in migraine drug prescriptions
4.1.2 Volume growth comparison: acute vs preventive medications
4.1.3 Trends in neurologist vs primary care prescribing patterns
4.2 Patient Demographics and Treatment Utilization (2024)
4.2.1 Gender-wise and age-wise migraine drug usAgedistribution
4.2.2 Urban vs rural prescription patterns and access
4.2.3 UsAgetrends among chronic vs episodic migraine sufferers
4.3 Drug Class and Pipeline Trends (2020–2025)
4.3.1 Market share by drug class: triptans, gepants, ditans, CGRP mAbs
4.3.2 Number of new migraine drugs approved annually (global)
4.3.3 Shift from oral drugs to injectables and nasal formulations
4.4 Access, Reimbursement, and Payer Mix (2024)
4.4.1 Insurance coverAgelevels for branded vs generic migraine drugs
4.4.2 Cost burden: out-of-pocket vs copay assistance vs public insurance
4.4.3 Impact of formulary restrictions on CGRP inhibitor uptake
4.5 Drug Pricing and Consumer Preference (2024)
4.5.1 AverAgeprice comparison of migraine drugs across brands and regions
4.5.2 Preference trends: oral vs injectable vs nasal spray formulations
4.5.3 Transparency in pricing and rise of patient discount programs
5. Migraine Drugs Market Segmental Analysis & Forecast, By Treatment, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Acute
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Preventive
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
6. Migraine Drugs Market Segmental Analysis & Forecast, By Route of Administration, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Oral
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Injectable
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Others
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
7. Migraine Drugs Market Segmental Analysis & Forecast, By Age, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Pediatric
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Adult
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Geriatric
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
8. Migraine Drugs Market Segmental Analysis & Forecast, By Availability, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Prescription Drugs
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Over-the-Counter (OTC) Drugs
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
9. Migraine Drugs Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.2.3 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.2.4 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.2.5 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.2.6 Migraine Drugs Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.2.6.1.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.2.6.1.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.2.6.1.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.2.6.2.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.2.6.2.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.2.6.2.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.3.3 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.4 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.3.5 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.3.6 Migraine Drugs Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.3.6.1.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.1.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.3.6.1.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.3.6.2.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.2.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.3.6.2.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.3.6.3.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.3.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.3.6.3.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.3.6.4.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.4.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.3.6.4.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.3.6.5.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.5.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.3.6.5.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.3.6.6.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.6.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.3.6.6.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.3.6.7.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.7.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.3.6.7.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.3.6.8.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.3.6.8.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.3.6.8.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.4.3 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.4 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.4.5 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.4.6 Migraine Drugs Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.4.6.1.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.1.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.4.6.1.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.4.6.2.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.2.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.4.6.2.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.4.6.3.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.3.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.4.6.3.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.4.6.4.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.4.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.4.6.4.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.4.6.5.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.5.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.4.6.5.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.4.6.6.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.6.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.4.6.6.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.4.6.7.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.4.6.7.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.4.6.7.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.5.3 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.4 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.5.5 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.5.6 Migraine Drugs Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.5.6.1.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.6.1.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.5.6.1.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.5.6.2.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.6.2.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.5.6.2.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.5.6.3.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.6.3.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.5.6.3.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.5.6.4.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.6.4.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.5.6.4.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.5.6.5.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.5.6.5.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.5.6.5.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.6.3 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.4 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.6.5 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.6.6 Migraine Drugs Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.6.6.1.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.1.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.6.6.1.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.6.6.2.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.2.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.6.6.2.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.6.6.3.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.3.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.6.6.3.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.6.6.4.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.4.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.6.6.4.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.6.6.5.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.5.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.6.6.5.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Migraine Drugs Market Size & Forecast, By Treatment, 2021 – 2032
9.6.6.6.2 Migraine Drugs Market Size & Forecast, By Route of Administration, 2021 – 2032
9.6.6.6.3 Migraine Drugs Market Size & Forecast, By Age, 2021 – 2032
9.6.6.6.4 Migraine Drugs Market Size & Forecast, By Availability, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 AbbVie Inc.
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Pfizer Inc.
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Eli Lilly and Company
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Teva Pharmaceuticals
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Amgen Inc.
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Novartis AG
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Lundbeck A/S
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 H. Lundbeck A/S
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Biohaven Ltd.
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Satsuma Pharmaceuticals
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Zosano Pharma
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Impel Pharmaceuticals
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Axsome Therapeutics
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Tonix Pharmaceuticals
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Dr. Reddy’s Laboratories
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 Sun Pharma
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Mylan
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 GSK plc
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 Boehringer Ingelheim
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Aurobindo Pharma
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
